GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alkermes, Inc. (ALKS) [hlAlert]

Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and
only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
( Total: 23 Current Stock Recommendations )
Alkermes, Inc.   (23)
Sell Hold 43% Buy 43%
Related companies
China Biologic ...   (4)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Talecris ...   (4)
Buy 100%
Anacor ...   (6)
Buy 100%
Santarus, Inc.   (13)
Hold 31% Buy 69%
Cardinal Health, ...   (24)
Hold 29% Buy 71%
Incyte Corporation   (22)
Sell Hold Buy 82%
Nbty, Inc.   (9)
Hold 44% Buy 56%
Dr. Reddy's ...   (5)
Sell 20% Hold 40% Buy 40%
Salix ...   (31)
Hold 39% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
12/18/2007  
Buy
  
6/5/2008  
Buy
  
6/30/2008  
Buy
  
3/6/2009  
Hold
  
3/26/2009  
Hold
  
4/3/2009  
Hold
  
4/13/2009  
Hold
  
2/5/2010  
Buy
  
5/19/2010  
Buy
  
10/20/2010  
Hold
  
10/26/2012  
Buy
  
1/17/2013  
Hold
  
4/22/2013  
Hold
  
4/26/2013  
Sell
  
5/29/2013  
Buy
  
10/30/2013  
Hold
  
2/28/2014  
Hold
  
2/28/2014  
Sell
  
7/31/2014  
Buy
  
5/21/2015  
Buy
  
1/21/2016  
Buy
  
1/21/2016  
Hold
  
1/21/2016  
Sell
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy